abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Historical Holders from Q3 2014 to Q1 2025

Symbol
HQL on NYSE
CUSIP
87911K100
Type / Class
Equity / Common Shares, $0.01 par value
Shares outstanding
28.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
9.41M
Holdings value
$123M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
71
Number of buys
26
Number of sells
-31
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 11.36% $44.2M 3.19M Saba Capital Management, L.P. Mar 31, 2025

Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 168K $2.15M -$1.08M $12.69 7
2024 Q4 9.41M $123M -$6.09M $13.12 71
2024 Q3 9.81M $148M +$3.78M $15.08 73
2024 Q2 8.74M $124M +$7.65M $14.17 73
2024 Q1 9.1M $124M +$15M $13.63 79
2023 Q4 7.9M $106M +$23.5M $13.46 77
2023 Q3 5.73M $71.5M +$11.5M $12.47 77
2023 Q2 20.7K $280K -$299K $10.27 2
2023 Q1 5.19M $72.2M +$252K $13.93 77
2022 Q4 5.21M $74.2M +$13.5M $14.21 78
2022 Q3 4.24M $58M +$8.3M $13.66 57
2022 Q2 3.67M $52.3M +$390K $14.23 62
2022 Q1 3.66M $60.6M -$3.61M $16.54 61
2021 Q4 3.87M $74.4M -$4.35M $19.23 62
2021 Q3 4.08M $85.1M -$6.8M $20.80 61
2021 Q2 4.39M $94.2M -$7.77M $21.44 63
2021 Q1 4.76M $93.8M -$3.06M $19.71 59
2020 Q4 4.9M $96.9M +$4.28M $19.75 61
2020 Q3 4.67M $82.1M +$2.72M $17.58 56
2020 Q2 4.59M $82.5M +$2.22M $17.96 65
2020 Q1 4.25M $63.7M +$3.45M $14.98 63
2019 Q4 4.08M $71.2M +$10.1M $17.43 62
2019 Q3 3.07M $46.4M +$1.93M $15.10 55
2019 Q2 3.17M $53.3M -$108K $16.85 50
2019 Q1 3.2M $54.7M -$1.46M $17.13 51
2018 Q4 3.26M $49.2M +$630K $15.11 53
2018 Q3 3.15M $64.4M -$131K $20.42 52
2018 Q2 3.2M $60.2M -$51.3K $18.79 57
2018 Q1 2.53M $48.4M +$1.6M $19.21 53
2017 Q4 2.43M $47.8M +$3.27M $19.63 52
2017 Q3 2.04M $43.9M +$4.13M $21.48 49
2017 Q2 2.23M $46.5M +$7.3K $20.85 41
2017 Q1 2.27M $43.9M -$1.38M $19.39 38
2016 Q4 2.57M $43.8M +$3.77M $16.99 44
2016 Q3 2.17M $40.7M -$925K $18.73 41
2016 Q2 2.23M $38.3M -$3.68M $17.19 46
2016 Q1 1.72M $30.8M -$4.72M $17.94 41
2015 Q4 2.62M $61.8M +$3.68M $23.64 45
2015 Q3 2.46M $55.6M +$3.05M $22.51 40
2015 Q2 2.3M $65M +$5.33M $28.21 39
2015 Q1 2.11M $58.2M -$948K $27.57 38
2014 Q4 2.15M $53.5M +$51.5M $24.88 37
2014 Q3 2.88K $64K +$64K $22.15 2